William P. Forbes - Jul 19, 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Chief Development Officer
Signature
/s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
Stock symbol
HRTX
Transactions as of
Jul 19, 2025
Transactions value $
$0
Form type
4
Date filed
7/22/2025, 12:43 PM
Previous filing
Jun 9, 2025
Next filing
Aug 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Forbes William P EVP, Chief Development Officer 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/ Kathryn Lester Attorney-in-Fact for William P. Forbes 2025-07-22 0001314760

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +3.87K +2.87% 139K Jul 19, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -3.87K -9.09% $0.00 38.7K Jul 19, 2025 Common Stock 3.87K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).